Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

Bliv review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

FDA warning letter #721479 (Feb. 2026), which names Bliv's website. An explicitly no-video-visit, fully async intake — as low as $116/mo semaglutide, $199/mo tirzepatide — with CareCredit and Klarna pay-later options, though no content addresses postpartum or PCOS. It also runs a member community on Skool, with dietitian-led nutrition guidance folded into that access rather than billed separately.

As low as $116/mo

Consult Medication Shipping
See plans at Bliv
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

Bliv at a glance

Semaglutide
As low as $116/mo
Tirzepatide
As low as $199/mo
Coverage
Not disclosed — no published state list
Brand-name
Compounded only

How we scored Bliv

Every factor comes from Bliv's own published pricing, disclosures and oversight, and the six combine into the 46/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance30/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit35/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs50/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost60/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support55/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness55/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Bliv Wellness LLC dba Bliv holds FDA warning letter #721479, dated 20 February 2026. A warning letter is worth reading before you sign up; it is not by itself a reason to rule a provider out. $116 for semaglutide and $199 for tirzepatide, both framed as 'as low as' in the homepage pricing section rather than as rates you can count on. Bliv publishes no state-coverage page and no FAQ answer on the subject, so where it operates stays unknown until you apply.

Before you sign up

What Bliv's public site and signup page show before you hand over any details.

Worth knowing

  • Homepage lists 'as low as $X per month' starting prices for both molecules directly, no intake required to see the numbers
  • States the intake is 'No Phone Calls. No Video visit' — a fully asynchronous review
  • Also offers CareCredit (24 months 0%) and Klarna pay-later financing, starting around $29/mo
  • Claims '30,000+ happy customers' as a trust signal
  • Explicitly states no video visit is required — one of the clearer async-intake claims
  • 'As low as' framing means the exact price at a working dose isn't guaranteed by the homepage number
  • No state-coverage list found on the pages checked
  • No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS

Pricing

MedicationPricePlan
Compounded semaglutide$116Starting priceListed as '*as low as $116 per month' — based on plan structure and eligibility.
Compounded tirzepatide$199Starting priceListed as '*as low as $199 per month' — based on plan structure and eligibility.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Bliv's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Explicitly states no phone call or video visit is required for the intake
  • CareCredit (24 months 0%) and Klarna pay-later financing offered, starting around $29/mo
  • Claims 30,000+ customers as a trust signal
  • Both molecules available with real starting prices

The caveats

  • FDA warning letter #721479, dated February 20, 2026, to Bliv Wellness LLC dba Bliv, for false or misleading claims and misbranding — the letter names its own site
  • No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
  • Both prices are framed as 'as low as' — the exact cost at a working dose isn't guaranteed
  • No state-coverage list published on the pages checked
  • No named compounding pharmacy or medical director found on the pages checked

Financing is not the medication price

Bliv advertises compounded semaglutide from $116 per month and compounded tirzepatide from $199 per month. The amount depends on the plan and eligibility, with the exact working-dose price not established by the starting figures. Ask for the prescription-specific charge, supply period, and commitment. A lower advertised minimum can help identify a service to investigate, but it cannot establish what every patient pays through later stages of treatment.

The site also promotes CareCredit financing and Klarna payment options. An installment around $29 is a financing payment, not a complete monthly medication price. A promotional 0% term depends on eligibility and the agreement offered to the applicant; it should not be treated as a guarantee for everyone. Compare the total purchase obligation and the repayment conditions separately from the medication supply. A smaller installment can spread a larger commitment without making the underlying care less expensive.

The FDA letter is material context

The FDA issued a warning letter dated February 20, 2026, to Bliv Wellness LLC doing business as Bliv, identifying Bliv's website. That specific company and site connection is relevant to evaluating this service and should remain visible alongside its price. A warning letter is a regulatory action, not a clinical assessment of an individual patient. It is also not a basis for claiming that every dispensed prescription has been tested and found harmful.

Read the actual regulatory concerns rather than treating a logo, testimonial, or ingredient name as a complete safety assessment. Compounded medications are not FDA approved and should not be assumed equivalent to a branded product. Before buying, ask the clinician why the particular formulation is appropriate and obtain the dispensing pharmacy's identity. The pharmacy label, concentration, quantity, storage, and instructions should be clear. These practical questions remain necessary regardless of whether the starting price fits your budget.

An asynchronous service still needs clinical access

Bliv describes an online process that does not require a live phone or video encounter at entry. That can be convenient, but it does not guarantee that no applicant will ever need additional clinical contact. Ask who reviews the information, how more complex questions are handled, and how to reach the prescribing team afterward. A short digital entry process should not be mistaken for a description of every possible treatment decision or follow-up appointment.

The program also promotes a member community with nutrition guidance. Community support can complement care, but it should not be treated as a replacement for individual advice about medication or a guarantee of specialist access. The company's claim of serving 30,000 customers is a marketing claim, not an independently established outcome measure. Neither participation numbers nor other members' experiences can predict your results or answer whether a prescription fits your medical history.

Get the commitment and identities in writing

Bliv does not publish a complete state list or clearly identify a dispensing pharmacy or medical director. Confirm availability where you live and identify the actual clinician and pharmacy serving you. If pregnancy planning, breastfeeding, or postpartum circumstances affect care, ask about them directly. The public presentation does not establish specific maternal-health expertise, and broad language about personalization should not fill that gap.

Bliv may interest someone who values asynchronous access and payment flexibility, but those conveniences need a clear underlying offer. Request the total obligation, renewal terms, financing conditions, and cancellation and refund policies before committing. Keep the FDA letter in view as part of the decision, together with the service's response to concrete clinical and dispensing questions. The useful comparison is the full prescription and care arrangement, rather than either the lowest starting amount or the smallest installment displayed.

The bottom line for mothers

Best for: Mothers who specifically want to avoid a scheduled video call and are comfortable confirming their state eligibility and real working-dose price at intake.

Alternatives to Bliv

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Compounded injections with free coaching and no membership — a fair budget pick if a 12-month plan suits you, since the 'from $119' price needs one and the month-to-month price shows only at checkout.

    Visit Oak
  • 10-week GLP-1 protocols — $299 semaglutide, $549 tirzepatide, about $130 and $238 a month — from a named physician who personally reviews every intake, inside a much broader peptide-and-longevity menu where GLP-1 is two SKUs among many.

    Visit Live Vital

Providers like Bliv

Keep comparing Bliv

Bliv, answered

How much does Bliv cost?
Bliv does not establish a comparable recurring monthly medication rate. Published pricing: As low as $116/mo for semaglutide; As low as $199/mo for tirzepatide. Ask for the complete charge, supply period and renewal terms before committing.
Is Bliv safe to use while breastfeeding?
No GLP-1 is established as safe in pregnancy. For breastfeeding, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels report little or no data on the drug in breast milk and ask you and your clinician to weigh the benefits of breastfeeding against your need for the medicine. Compounded versions carry no label of their own, which puts more of that judgment on your prescriber. Bliv is not an exception to any of that — settle the timing with your own clinician.
Does Bliv offer both semaglutide and tirzepatide?
Yes — Bliv offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
How does Bliv score for mothers?
Bliv scores 46/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.

Pricing, states and verification reflect Bliv's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers